Literature DB >> 23562670

Dopaminergic modulation of tonic but not phasic GABAA-receptor-mediated current in the ventrobasal thalamus of Wistar and GAERS rats.

Josue G Yagüe1, Anna Cavaccini, Adam C Errington, Vincenzo Crunelli, Giuseppe Di Giovanni.   

Abstract

Activation of GABA(A) receptors by GABA causes phasic and tonic conductances in different brain areas. In the ventrobasal (VB) thalamus, tonic inhibition originates from GABA acting on extrasynaptic receptors. Here we show that dopamine (DA), the D2-like agonist quinpirole and the selective D4R agonist PD-168,077 decrease the magnitude of the tonic GABA(A) current while D1-like agonist SKF39383 lacks any significant effects in VB neurons of Wistar rats. On the other hand, DA and D1/D2 receptor activation does not alter phasic GABA(A) conductance. As we previously reported that an increased tonic GABA(A) current in VB neurons is critical for absence seizure generation, we also investigated whether D2-D4 receptor activation is capable of normalizing this aberrant conductance in genetic absence epilepsy rats from Strasbourg (GAERS). Quinpirole and PD-168,077 selectively reduces tonic GABA(A) current as in normal rats. Therefore, it is conceivable that some DA anti-absence effects occur via modulation of tonic GABA(A) current in the VB.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Absence epilepsy; Dopamine; GABA(A) receptors; Patch-clamp; Tonic inhibition; Ventrobasal thalamus

Mesh:

Substances:

Year:  2013        PMID: 23562670     DOI: 10.1016/j.expneurol.2013.03.023

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  The substantia nigra conveys target-dependent excitatory and inhibitory outputs from the basal ganglia to the thalamus.

Authors:  Miklos Antal; Brandon M Beneduce; Wade G Regehr
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

2.  Enhanced GABAA-Mediated Tonic Inhibition in Auditory Thalamus of Rats with Behavioral Evidence of Tinnitus.

Authors:  Evgeny A Sametsky; Jeremy G Turner; Deb Larsen; Lynne Ling; Donald M Caspary
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

3.  Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.

Authors:  Philippe De Deurwaerdère; Maurizio Casarrubea; Daniel Cassar; Manuela Radic; Emilie Puginier; Abdeslam Chagraoui; Giuseppe Crescimanno; Vincenzo Crunelli; Giuseppe Di Giovanni
Journal:  Front Cell Neurosci       Date:  2022-05-23       Impact factor: 6.147

Review 4.  Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?

Authors:  Bruno P Guiard; Giuseppe Di Giovanni
Journal:  Front Pharmacol       Date:  2015-03-17       Impact factor: 5.810

Review 5.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

6.  Acute and Chronic Dopaminergic Depletion Differently Affect Motor Thalamic Function.

Authors:  Giuseppe Di Giovanni; Laura Clara Grandi; Ernesto Fedele; Gergely Orban; Agnese Salvadè; Wei Song; Eleonora Cuboni; Alessandro Stefani; Alain Kaelin-Lang; Salvatore Galati
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

Review 7.  The Pharmacology of Visual Hallucinations in Synucleinopathies.

Authors:  Mirella Russo; Claudia Carrarini; Fedele Dono; Marianna Gabriella Rispoli; Martina Di Pietro; Vincenzo Di Stefano; Laura Ferri; Laura Bonanni; Stefano Luca Sensi; Marco Onofrj
Journal:  Front Pharmacol       Date:  2019-12-09       Impact factor: 5.810

Review 8.  Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures.

Authors:  Vincenzo Crunelli; Magor L Lőrincz; Cian McCafferty; Régis C Lambert; Nathalie Leresche; Giuseppe Di Giovanni; François David
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.